Blood marker may help doctors spot and treat respiratory failure before it worsens
NCT ID NCT07334379
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether measuring a blood marker called interleukin-6 (IL-6) can help doctors decide when to give anti-inflammatory drugs to patients hospitalized with acute respiratory failure. Patients with high IL-6 levels will receive either standard care, a single dose of tocilizumab, or a 10-day course of dexamethasone. The goal is to see if this approach is practical and can prevent the need for intensive care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tocilizumab (Actemra) and dexamethasone
- What this could lead to
- If successful, this approach could help doctors identify high-risk patients earlier and start targeted anti-inflammatory treatment to prevent severe complications like organ failure.
- What could go wrong
- This is a small, early feasibility study with only 60 participants, so results may not apply broadly. The treatments also carry risks like infection or side effects from steroids.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE HYPOXEMIC RESPIRATORY FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Toronto General Hospital
RECRUITINGToronto, Ontario, M5G 2N2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Low oxygen or organ failure? study aims to uncover true driver of ICU deaths
- AI could predict which ICU patients with breathing failure are at highest risk of death
- AI predicts ventilator duration in respiratory failure
- Can targeted sedation help patients breathe easier on oxygen therapy?
- Can a simple gas help severely obese patients breathe better on ventilators?
- Sedation may ease risky lung exam in breathless patients